Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy, Tolerability, and Safety of 7 Days of Treatment With GRT6010 or Pregabalin in Comparison to Placebo in Subjects With Peripheral Neuropathic Pain.

NCT01485094 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT01485094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01485094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy, Tolerability, and Safety of 7 Days of Treatment With GRT6010 or Pregabalin in Comparison to Placebo in Subjects With Peripheral Neuropathic Pain.
Lead sponsor
Grünenthal GmbH
Phase
Phase 2
Overall status
Terminated
Start date
February 29, 2012
Completion date
January 31, 2013
Enrollment
114 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

neuralgia